Novo Nordisk A/SNVONYSE
Loading
EPS Over TimeStrong
Percentile Rank100
3Y CAGR+23.4%
5Y CAGR+20.6%
Studio
Year-over-Year Change

Earnings per share

3Y CAGR
+23.4%/yr
vs +11.3%/yr prior
5Y CAGR
+20.6%/yr
Consistent
Acceleration
+12.1pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.6x
Strong expansion
Streak
9 yr
Consecutive growthStrong
PeriodValueYoY Change
202523.06+1.7%
202422.67+21.4%
202318.67+52.3%
202212.26+17.9%
202110.40+15.2%
20209.03+10.0%
20198.21+2.9%
20187.98+3.5%
20177.71+2.8%
20167.50-